ADVERTISEMENT
Zydus Cadila Gets USFDA Nod for Antibiotic Capsules
19 Feb 2016, 04:22 PM IST i


New Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market its generic Doxycycline capsules used for the treatment of bacterial infections in the American market.
"Zydus Cadila has received approval from the United States Food and Drug Administration (USFDA) to market Doxycycline capsules USP, 50 mg, 75 mg, and 100 mg," Cadila Healthcare said in a BSE filing.
The drug falls in the anti-bacteria...
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
ADVERTISEMENT